Steris PLC (NYSE:STE) Director Richard Martin Steeves sold 5,854 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $153.77, for a total value of $900,169.58. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Richard Martin Steeves also recently made the following trade(s):
- On Monday, December 2nd, Richard Martin Steeves sold 5,960 shares of Steris stock. The stock was sold at an average price of $150.75, for a total value of $898,470.00.
Shares of STE stock traded up $1.99 during trading on Wednesday, reaching $154.07. The company’s stock had a trading volume of 471,410 shares, compared to its average volume of 469,005. The business has a fifty day moving average price of $145.59 and a 200-day moving average price of $145.58. The company has a quick ratio of 1.86, a current ratio of 2.41 and a debt-to-equity ratio of 0.73. The company has a market cap of $12.81 billion, a price-to-earnings ratio of 31.51 and a beta of 0.89. Steris PLC has a one year low of $99.14 and a one year high of $156.66.
Steris (NYSE:STE) last announced its earnings results on Monday, November 4th. The medical equipment provider reported $1.32 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.26 by $0.06. The business had revenue of $736.84 million during the quarter, compared to analysts’ expectations of $717.79 million. Steris had a net margin of 11.59% and a return on equity of 16.15%. The firm’s revenue was up 8.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.10 earnings per share. Research analysts anticipate that Steris PLC will post 5.6 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Tuesday, November 26th will be given a dividend of $0.37 per share. The ex-dividend date of this dividend is Monday, November 25th. This represents a $1.48 annualized dividend and a yield of 0.96%. Steris’s dividend payout ratio (DPR) is presently 30.27%.
Several institutional investors have recently bought and sold shares of STE. Invesco Ltd. grew its holdings in shares of Steris by 103.3% in the 2nd quarter. Invesco Ltd. now owns 1,141,634 shares of the medical equipment provider’s stock valued at $169,967,000 after acquiring an additional 579,965 shares in the last quarter. BlackRock Inc. increased its position in shares of Steris by 6.1% in the second quarter. BlackRock Inc. now owns 9,052,709 shares of the medical equipment provider’s stock valued at $1,347,769,000 after acquiring an additional 522,254 shares during the last quarter. JPMorgan Chase & Co. raised its holdings in Steris by 165.1% during the second quarter. JPMorgan Chase & Co. now owns 792,562 shares of the medical equipment provider’s stock worth $116,142,000 after acquiring an additional 493,578 shares in the last quarter. Nuveen Asset Management LLC bought a new stake in Steris during the second quarter worth about $68,419,000. Finally, TimesSquare Capital Management LLC bought a new stake in Steris during the second quarter worth about $60,058,000. Institutional investors own 86.77% of the company’s stock.
Separately, ValuEngine lowered Steris from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $148.20.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.